Pulmonx Corp (STU:4NI)
€ 6.8 0.05 (0.74%) Market Cap: 272.17 Mil Enterprise Value: 224.02 Mil PE Ratio: 0 PB Ratio: 3.09 GF Score: 59/100

Pulmonx Corp at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 04:45PM GMT
Release Date Price: €17.5 (-26.47%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Thank you, everybody, and I can still say good morning for another 15 minutes. But I'm Joanne Wuensch, the Citi MedTech analyst, for those of you who don't know me. I'm very pleased for this session to have the management team from Pulmonx, both Glen French and Derrick Sung, join us. So thank you for joining us.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

Thank you.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

I have a whole list of questions here, and I can trash them now because last evening, you -- some may call it pull the band-aid off. Some might say conservatively. I'd be curious your view, updated everybody on guidance. So I think that's where we should start.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

It's been a little buzz around the guidance. So, yes. So for those who might be new to our story, we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot